| Good glycemic control group (n = 46) | Poor glycemic control group (n = 56) | P value |
---|---|---|---|
Male, n (%) | 33 (71.7) | 40 (71.4) | 0.972 |
Age, years | 61.83 ± 9.34 | 65.43 ± 6.73 | 0.026 |
Body mass index, Kg/m2 | 28.41 ± 2.59 | 28.16 ± 2.55 | 0.622 |
Cigarette smoking, n (%) | 17 (37.0) | 22 (56.4) | 0.810 |
Hypertension, n (%) | 30 (65.2) | 45 (80.4) | 0.085 |
Systolic blood pressure, mm Hg | 135.35 ± 19.01 | 141.77 ± 18.69 | 0.090 |
Diastolic blood pressure, mm Hg | 74.85 ± 10.69 | 77.82 ± 12.42 | 0.204 |
Fasting blood glucose, mmol/L | 6.03 ± 0.81 | 6.90 ± 2.08 | 0.009 |
HbA1c, % | 6.53 ± 0.31 | 8.13 ± 1.29 |  < 0.001 |
Serum creatinine, μmol/L | 77.04 ± 15.21 | 78.70 ± 17.55 | 0.615 |
Serum uric acid, μmol/L | 345.76 ± 79.73 | 345.98 ± 82.74 | 0.989 |
GFR, mL/min/1.73m2 | 86.83 ± 14.70 | 83.29 ± 14.47 | 0.225 |
Triglyceride, mmol/L | 1.39 ± 0.84 | 1.92 ± 1.75 | 0.064 |
Total cholesterol, mmol/L | 3.84 ± 0.88 | 3.89 ± 1.06 | 0.810 |
HDL cholesterol, mmol/L | 1.23 ± 0.28 | 1.14 ± 0.25 | 0.100 |
LDL cholesterol, mmol/L | 2.25 ± 0.80 | 2.21 ± 0.74 | 0.804 |
Apolipoprotein A, g/L | 1.24 ± 0.16 | 1.17 ± 0.19 | 0.076 |
Apolipoprotein B, g/L | 0.75 ± 0.33 | 0.75 ± 0.20 | 0.975 |
Lipoprotein (a), g/L | 0.25 ± 0.27 | 0.33 ± 0.35 | 0.220 |
hsCRP, mg/L | 1.18 (0.47–3.04) | 2.16 (1.19 ~ 5.76) | 0.002 |
Presence of CAD, n (%) | 17 (37.0) | 38 (67.9) | 0.002 |
SYNTAX score | 7.28 ± 10.54 | 15.88 ± 16.36 | 0.003 |
Gensini score | 15.07 ± 21.03 | 48.99 ± 48.88 |  < 0.001 |
Medication, n (%) | Â | Â | Â |
 ACE inhibitors/ARBs | 25 (54.3) | 27 (48.2) | 0.538 |
 β-blockers | 28 (60.9) | 40 (71.4) | 0.260 |
 Calcium channel blockers | 13 (28.3) | 14 (25.0) | 0.710 |
 Statins | 43 (93.5) | 49 (87.5) | 0.312 |
Flow mediated dilation, % | 6.94 ± 2.20 | 6.03 ± 2.08 | 0.036 |